J Korean Neurol Assoc.  2019 Feb;37(1):1-7. 10.17340/jkna.2019.1.1.

A New Biological Definition of Alzheimer's Disease: Introduction of 2018 National Institute on Aging-Alzheimer's Association Research Framework

Affiliations
  • 1Department of Neurology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chouncheon, Korea.
  • 2Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea. neuroksy@snu.ac.kr

Abstract

Diagnostic guidelines for the preclinical, mild cognitive impairment, and dementia stages of Alzheimer's disease (AD) were released by the National Institute on Aging and Alzheimer's Association (NIA-AA) in 2011. Promoted by the subsequent scientific progress, a unifying update, the "˜NIA-AA Research Framework', was published in 2018. This new research framework shifts the definition of AD from syndrome to biological construct based on biomarkers in living people. The biomarkers were grouped into β amyloid deposition (A), pathologic tau (T), and neurodegeneration (N) related, termed the "˜AT(N) classification system#x2019;, which could be extended with new biomarkers as they become available in the future. For the staging of cognitive impairment, three syndromal stages for observational studies and six numeric stages for clinical trials were also suggested. This biomarker-based classification combined with clinical staging is expected to enhance the understanding of AD as well as aid in precise targeting for interventional clinical trials. This review focused on the introduction of the new 2018 NIA-AA Research Framework. Although this framework has been proposed for research purposes, it is expected to be adopted into general clinical practice with thorough examination and validation in the future.

Keyword

Alzheimer disease; Research; Biomarkers

MeSH Terms

Alzheimer Disease*
Biomarkers
Classification
Cognition Disorders
Dementia
Mild Cognitive Impairment
National Institute on Aging (U.S.)
Plaque, Amyloid
Biomarkers
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr